Atrial Fibrillation in Young Patients: a Prospective Multicentre Registry
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- University Hospital, Caen
- Enrollment
- 200
- Locations
- 1
- Primary Endpoint
- Recurrent symptomatic atrial fibrillation.
Study Overview
Brief Summary
Atrial fibrillation is a rare cardiac arrhythmia in young (i.e. <= 35-year-old) patients. Etiological factors, current management and mid- to long-term outcomes remain unknown.
Detailed Description
Atrial Fibrillation in YOUNG patients (YOUNG-AF) is a prospective, observational, multicentric registry, including every consecutive patients aged < 35-year-old with a diagnosis of atrial fibrillation. The registry will assess demographical, physical activity, toxicologic and genetic factors, as well as current management regarding anticoagulation, anti-arrhythmic drugs and catheter ablation. As an observational registry, patient will be managed with the guidelines-directed standard-of-care.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- — to 35 Years (Child, Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •First episode of atrial fibrillation
- •Less than 35-year-old
- •Diagnostic by 12-lead ECG or continuous monitoring (minimal duration 30 seconds)
- •French Social Security number
Exclusion Criteria
- •Transvenous cardiac implantable electronic device (insertable cardiac monitors are not an exclusion criteria)
Outcomes
Primary Outcomes
Recurrent symptomatic atrial fibrillation.
Time Frame: at 10-year
Incidence of symptomatic atrial fibrillation at 10-year after initial diagnosis of atrial fibrillation.
Composite of mortality, thromboembolic event and heart failure
Time Frame: at 10-year
Incidence of all-cause mortality, symptomatic thromboembolic event and congestive heart failure at 10-year after initial diagnosis of atrial fibrillation.
Secondary Outcomes
No secondary outcomes reported